Clinical Trials Logo

Clinical Trial Summary

The purpose of this study is to determine the benefits of "Visiobiane Anti-age" dietary supplement on macular pigment optical density, contrast sensibility and visual acuity. Additionally, the study would like to evaluate seric variations of carotenoids and the total antioxydant capacity.


Clinical Trial Description

Visiobiane study is a randomized trial of 30 participants designed to assess the effects of oral supplementation of macular xanthophylls (lutein and zeaxanthin) and omega-3 LCPUFAs for the eyes protection. The study will enroll healthy participants aged 45 to 55 years. 15 subjects will be assigned in placebo group and 15 in experimetal group (Visiobiane anti-age). They will be supplemented for 24 weeks ;


Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double-Blind, Primary Purpose: Prevention


Related Conditions & MeSH terms


NCT number NCT00449917
Study type Interventional
Source Pileje
Contact
Status Completed
Phase Phase 4
Start date September 2006
Completion date November 2007

See also
  Status Clinical Trial Phase
Recruiting NCT05251792 - Macular Pigment Optical Density in Primary Angle-closure Disease
Completed NCT03983525 - The Effect of Gojiberry Intake (Lycium Barbarium) on Macular Function N/A
Recruiting NCT03433885 - Wenzhou Dry Age-related Macular Degeneration (AMD) Progression Study